Our laboratory primarily uses genomic and biochemical approaches to investigate molecular mechanisms of prostate cancer development and progression in preclinical models. Our current research focuses on androgen receptor signaling, WNT signaling, DNA repair pathways and their therapeutic potential in prostate cancer. The goal of our research is to help clinicians use existing treatments more accurately and develop novel treatments for incurable castration-resistant prostate cancer.